Development of a Brief Validated Geriatric Depression Screening Tool: The SLU “AM SAD”

Chakkamparambil, Binu; Chibnall, John T.; Graypel, Ernest A.; Manepalli, Jothika; Bhutto, Asif; Grossberg, George T.

doi:10.1016/j.jagp.2014.10.003

Cited by 20 publications

(5 citation statements)

References 9 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An independent random sample of 500 responses was extracted from the larger database for these analyses. Model fit (with acceptable thresholds) was explored through the comparative fit index (CFI, > 0.95) [25], the Tucker Lewis Index (TLI, > 0.95) [25] and root mean square error of approximation (RMSEA, < 0.07) [26]. Modification indices were used as necessary to identify any potential modifications for improving fit (e.g.…”

Section: Confirmatory Factor Analysismentioning

confidence: 99%

Creation and validation of the 4-item BriefPCS-chronic through methodological triangulation

Walton

Mehta

Seo

et al. 2020

Health Qual Life Outcomes

View full text Add to dashboard Cite

Background: The Pain Catastrophizing Scale (PCS) is a widely used self-report tool to evaluate pain related catastrophizing. The PCS was developed using classical test theory and has been shown to be psychometrically sound among various populations. However, it's current three subscales are rarely used in clinical practice, offering potential for an abbreviated version that reduces administrative burden and can be used to estimate full scale scores, yet is not bound by the inclusion of items from each subscale. Hence, the aim of the current study was to develop a unidimensional abbreviated version of the PCS through findings from qualitative, classical test theory, and newer Rasch analysis. Methods: The current cross-sectional study used data from the Quebec Pain Registry (n = 5646) to obtain PCS scores of people seeking care at tertiary chronic pain centres. To develop an abbreviated unidimensional tool, items were removed based on triangulation of qualitative review of each item and response, corrected item-total correlations, and Rasch analysis. Confirmatory factor analysis was conducted on the final remaining items to confirm the tool was assessing a single latent construct (catastrophizing). Fit was assessed using the cumulative fit index (CFI), Tucker Lewis Index (TLI), and root-mean-squared error of approximation (RMSEA). Results: After triangulation, a final abbreviated 4-item scale showed adequate model fit with a strong correlation (r > 0.95) with the original scale and properties that were stable across age, sex, cause, and medicolegal status. Additionally, the brief version addressed some problematic wording on some items on the original scale. Both the original and new abbreviated tool were associated with the Beck Depression Inventory and the Brief Pain Inventory at the same magnitude. Conclusion: The abbreviated scale may allow for a decrease in administrator burden and greater clinical uptake when a quick screen for exaggerated negative orientation towards pain is needed.

show abstract

Section: Confirmatory Factor Analysismentioning

confidence: 99%

Creation and validation of the 4-item BriefPCS-chronic through methodological triangulation

Walton

Mehta

Seo

et al. 2020

Health Qual Life Outcomes

View full text Add to dashboard Cite

show abstract

“…For a shorter, and more practical, reliable geriatric depression screening instruments that can be used, especially in primary care, GDS-4 scale (including four questions) (van Marwijk et al, 1995) and GDS-5 scale (including five questions) (Hoyl et al, 1999) were developed, and they were validated for different languages (Rinaldi et al, 2003;Castelo et al, 2010). Besides, SLU "AM SAD" (including five questions), another short GDS was developed (Chakkamparambil et al, 2015), and it was validated in Turkish (Soysal et al, 2016).…”

Section: Introductionmentioning

confidence: 99%

The evaluation and design of a short depression screening tool in Turkish older adults

Dokuzlar

Soysal

Usarel

et al. 2018

Int. Psychogeriatr.

View full text Add to dashboard Cite

show abstract

“…63 The clinical interview with care partner and family input is vital to eliciting the core features of depression. 64 Once a diagnosis of clinically significant depression in a patient with an NDD is made and potentially reversible or contributory factors have been excluded, a biopsychosocial-environmental treatment plan is developed. The plan begins by addressing psychological and environmental stressors.…”

Section: Depressionmentioning

confidence: 99%

“…The 9-item Patient Health Questionnaire is helpful in detecting and quantifying mood and depression symptoms in NDDs . The clinical interview with care partner and family input is vital to eliciting the core features of depression …”

Section: Depressionmentioning

confidence: 99%

Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders

Cummings,

Lanctot,

Grossberg

et al. 2024

JAMA Neurol

View full text Add to dashboard Cite

ImportanceNeuropsychiatric syndromes (NPSs) are common in neurodegenerative disorders (NDDs); compromise the quality of life of patients and their care partners; and are associated with faster disease progression, earlier need for nursing home care, and poorer quality of life. Advances in translational pharmacology, clinical trial design and conduct, and understanding of the pathobiology of NDDs are bringing new therapies to clinical care.ObservationsConsensus definitions have evolved for psychosis, agitation, apathy, depression, and disinhibition in NDDs. Psychosocial interventions may reduce mild behavioral symptoms in patients with NDD, and pharmacotherapy is available for NPSs in NDDs. Brexpiprazole is approved for treatment of agitation associated with Alzheimer disease dementia, and pimavanserin is approved for treatment of delusions and hallucinations associated with psychosis of Parkinson disease. Trials are being conducted across several of the NDDs, and a variety of mechanisms of action are being assessed for their effect on NPSs.Conclusions and RelevanceDetection and characterization of NPSs in patients with NDDs is the foundation for excellent care. New definitions for NPSs in NDDs may inform choices regarding clinical trial populations and translate into clinical practice. Psychosocial and pharmacologic therapies may reduce behavioral symptoms and improve quality of life for patients and caregivers. Approved agents may establish regulatory precedents, demonstrate successful trial strategies, and provide the foundation for further advances in treatment development.

show abstract

Development of a Brief Validated Geriatric Depression Screening Tool: The SLU “AM SAD”

Cited by 20 publications

References 9 publications

Creation and validation of the 4-item BriefPCS-chronic through methodological triangulation

Creation and validation of the 4-item BriefPCS-chronic through methodological triangulation

The evaluation and design of a short depression screening tool in Turkish older adults

Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders

Contact Info

Product

Resources

About